title: [Ceftriaxone in treatment of streptococcal endocarditis].
abstract: The authors studied efficacy and safety of ceftriaxone given intravenously for 3-4 weeks in a dose 2-4 g/day to patients with streptococcal endocarditis (SE). Of them, 8, 8 and 1 patients were infected with Streptococcus viridans, Streptococcus pyogenes, Pneumococcus, respectively. Hospital trial and follow-up lasted up to 2 years. Cure without surgical correction occurred in 7 patients, valvular replacement was needed in 4 patients, 1 patient died, 4 patients developed recurrences 3 and more months after therapy with ceftriaxone. The drug was safe and well tolerated. 33% of the patients were discharged from hospital with obvious improvement after 2-3 week treatment to continue it outpatiently for 1-2 weeks.
authors.affiliation: Department of Hospital Therapy, Medical Institute, Novosibirsk.
authors.forename: A A
authors.initials: AA
authors.lastname: Demin
authors.forename: V P
authors.initials: VP
authors.lastname: Drobysheva
mesh_terms: D000328:Adult; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use*; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004698:Endocarditis, Subacute Bacterial / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D012008:Recurrence; D012449:Safety; D013290:Streptococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013291:Streptococcus / Q000302:isolation & purification; D016896:Treatment Outcome
chemical_list: D002511:Cephalosporins; D002443:Ceftriaxone
vernacular_title: Tseftriakson v lechenii streptokokkovogo 'endikardita.